-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Initial cohort of 500 solid tumors screened for Basket of Baskets
Study
EGAS00001005893
-
INSIGHT: VHL Case Report
Study
EGAS00001005895
-
Target gene sequencing for human normal endometrial glands
Study
EGAS00001005914
-
Genomic determination for Homologous Recombination Deficiency (HRD) by shallow Whole Genome Sequencing (sWGS)
Study
EGAS00001005926
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.
Study
EGAS00001005985
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_RNAseq)
Study
EGAS00001006002
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study
EGAS00001006007
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024
-
Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma
Study
EGAS00001006027
-
Whole genome sequencing of colorectal cancer patients (SG-BULK-1)
Study
EGAS00001006030
-
Genomewide copy number alteration screening of circulating plasma DNA
Study
EGAS00001006031
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
The KATHERINE study of adjuvant trastuzumab emtansine in HER2-positive breast cancer: analysis of patients with HER2-negative residual invasive disease on re-testing
Study
EGAS00001006037
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-2)
Study
EGAS00001006039
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-3)
Study
EGAS00001006056
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-5)
Study
EGAS00001006114
-
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Study
EGAS00001006059